Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer: a Copenhagen Breast Cancer Genomics Study

Estrogen receptor (ER) and human epidermal growth factor 2 (HER2) expression guide the use of neoadjuvant chemotherapy (NACT) in patients with early breast cancer. We evaluate the independent predictive value of adding a multigene profile (CIT256 and PAM50) to immunohistochemical (IHC) profile regar...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, M.-B., Pedersen, C. B., Misiakou, M.-A., Talman, M.-L. M., Gibson, L., Tange, U. B., Kledal, H., Vejborg, I., Kroman, N., Nielsen, F. C., Ejlertsen, B., Rossing, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232408/
https://www.ncbi.nlm.nih.gov/pubmed/37258527
http://dx.doi.org/10.1038/s41523-023-00551-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232408/
https://www.ncbi.nlm.nih.gov/pubmed/37258527
http://dx.doi.org/10.1038/s41523-023-00551-0

Ejemplares similares